Portfolio (Quarterly)
Guide ↗
Beirne Wealth Consulting Services, LLC
· CIK 0001697303| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 101 | NVAX | NOVAVAX INC | Healthcare | 15,000.0 | $141K | 0.03% | — | — | $9.42 | -5.9% |
| 102 | — | LINEAGE CELL THERAPEUTICS IN | — | 45,000.0 | $59K | 0.01% | — | — | $1.31 | — |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Technology
25.7%
Financial Services
19.5%
Energy
15.0%
Basic Materials
10.7%
Consumer Cyclical
8.3%
Healthcare
7.8%
Communication Services
5.5%
Industrials
4.2%
Utilities
3.3%